Study: Antibody for Severe Hemophilia A May Reduce Injections Needed to Prevent Bleeding
Dec 01, 2015
An antibody engineered to prevent excessive bleeding in patients with severe hemophilia A may be safe and effective, and require fewer injections than existing options, according to a first-in-human study of the treatment published online today in Blood, the Journal of the American Society of Hematology (ASH).
The American Society of Hematology and McMaster University Announce Partnership to Develop Clinical Practice Guidelines on Venous Thromboembolism
Nov 30, 2015
The American Society of Hematology, the world’s largest association of clinicians and scientists dedicated to conquering blood diseases, is collaborating with McMaster University, a world leader in guideline development and an international authority on thrombosis, to develop clinical practice guidelines on the diagnosis and treatment of venous thromboembolism.
Statement from ASH President David A. Williams, MD, on Need for Changes to Maintenance of Certification, Comments on Assessment 2020 Report
Nov 05, 2015
As the world’s largest professional society concerned with the causes and treatment of blood disorders, the American Society of Hematology’s membership includes most of the 8,400 internists who hold hematology certificates issued by the American Board of Internal Medicine (ABIM). For more than 14 years, ASH has actively challenged the ABIM’s Maintenance of Certification (MOC) program on a number of fronts, including the lack of evidence that the program’s requirements improve the quality of medical care.